Skip to main content
Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
17.84
-0.09 (-0.50%)
At close: Dec 20, 2024, 4:00 PM
18.00
+0.16 (0.90%)
After-hours: Dec 20, 2024, 4:02 PM EST

Innoviva Revenue

Innoviva had revenue of $89.51M in the quarter ending September 30, 2024, with 33.08% growth. This brings the company's revenue in the last twelve months to $352.75M, up 21.46% year-over-year. In the year 2023, Innoviva had annual revenue of $310.46M, down -6.30%.

Revenue (ttm)
$352.75M
Revenue Growth
+21.46%
P/S Ratio
3.19
Revenue / Employee
$3,149,509
Employees
112
Market Cap
1.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K0.00%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 2.01B
Embecta 1.12B
Myriad Genetics 823.60M
Artivion 384.90M
CareDx 312.78M
Ardelyx 251.85M
Weave Communications 195.84M
Syndax Pharmaceuticals 16.00M
Revenue Rankings

INVA News

More News